U.S. President Donald Trump announced on Friday, 31 July, that Hamas has agreed to a plan for the “complete disarmament” of the group and other armed factions in Gaza as part of the second phase of a U.S.-brokered ceasefire initiative. According to Trump, the agreement was reached through the Board of Peace, an international body established under his Gaza peace plan. In a post on Truth Social, he said the deal marks a “major milestone” toward ending the conflict and thanked Egypt, Qatar, and Türkiye for their mediation efforts. A senior Hamas official also told the BBC that the group had agreed to the Board of Peace’s proposal to fully disarm in Gaza and said an official statement would be issued soon. Trump said the agreement envisions a phased Israeli withdrawal from Gaza as the disarmament process is completed, with an international stabilization force and a new Palestinian police force taking responsibility for security in the territory. The Board of Peace announced that the agreement followed months of negotiations and that its focus has now shifted to implementation. The body was established under Trump’s 20-point Gaza peace plan, which includes…
This content is for members only. Visit the site and log in/register to read.Trump Says Hamas Agrees to Disarm Under Gaza Peace Plan first appeared on Egyptian Streets.
Hence then, the article about trump says hamas agrees to disarm under gaza peace plan was published today ( ) and is available on Egyptian Streets ( Egypt ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Trump Says Hamas Agrees to Disarm Under Gaza Peace Plan )
Also on site :
- Tributes pour in for 38-year-old British woman found dead in suitcase in Athens: ‘Beautiful, loving and kind’
- Walmart’s Lettuce-Trim Matching Set Is ‘Comfortable’ Enough to Sleep in and ‘Cute’ Enough to Wear Out
- CellOrigin Unveils Two Novel Solid-Tumor Cell Therapy Candidates at ASCO 2026, Partners with Walvax for In Vivo CAR Clinical Trial